In-situ Hybridization Market Size - By Product (Consumables, Instruments, Services), Technology (Fluorescent In-Situ Hybridization, Chromogenic In-Situ Hybridization), Application (Cancer, Cytogenetics, Immunology), End-use & Forecast 2024 - 2032

Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Increasing prevalence of target disorders 3.2.1.2 Technological advancement in the field of in-vitro diagnostics 3.2.1.3 Rising R&D investments in in-vitro diagnostics 3.2.2 Industry pitfalls & challenges 3.2.2.1 High cost of in-situ hybridization 3.2.2.2 Presence of an ambiguous regulatory framework 3.3 Growth potential analysis 3.4 Technological landscape 3.5 Regulatory landscape 3.6 Porter's analysis 3.7 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company market share analysis 4.3 Competitive positioning matrix 4.4 Strategy outlook matrix Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Consumables 5.2.1 Probes 5.2.2 Kits and reagents 5.2.3 Accessories 5.3 Instruments 5.4 Services Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Fluorescent in-situ hybridization 6.2.1 DNA fluorescent in-situ hybridization 6.2.2 RNA fluorescent in-situ hybridization 6.2.3 PNA fluorescent in-situ hybridization 6.3 Chromogenic in-situ hybridization Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Cancer 7.3 Cytogenetics 7.4 Developmental biology 7.5 Infectious diseases 7.6 Neuro science 7.7 Immunology 7.8 Other applications Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 Hospitals and diagnostic laboratories 8.3 Academic and research institutes 8.4 Contract research organizations 8.5 Pharmaceuticals and biotechnology companies 8.6 Other end-users Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 9.1 Key trends 9.2 North America 9.2.1 U.S. 9.2.2 Canada 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 France 9.3.4 Spain 9.3.5 Italy 9.3.6 Netherlands 9.3.7 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 South Korea 9.4.6 Rest of Asia Pacific 9.5 Latin America 9.5.1 Brazil 9.5.2 Mexico 9.5.3 Argentina 9.5.4 Rest of Latin America 9.6 Middle East and Africa 9.6.1 Saudi Arabia 9.6.2 South Africa 9.6.3 UAE 9.6.4 Rest of Middle East and Africa Chapter 10 Company Profiles 10.1 Agilent Technologies, Inc. 10.2 Bio-Techne Corporation 10.3 Bio-Rad Laboratories, Inc. 10.4 Bio View Ltd. 10.5 Danaher Corporation 10.6 Merck KGaA 10.7 Neogenomics, inc. 10.8 PerkinElmer, Inc. 10.9 Sysmex Corporation 10.10 Thermo Fisher Scientific Inc.